← All News
Al Jazeera · 1 min read

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.

This is a summary aggregated from Al Jazeera. Read the complete article on the original site:

Read full article at Al Jazeera

More Health & Medical News

Ultragenyx wins accelerated approval of gene therapy for glycogen storage disease

Seeking Alpha · 25 min ago

What season-ending injury to No. 1 pick Azzi Fudd means for Wings' WNBA playoff chances

Yahoo Sports · 33 min ago

Testing the claim: a degraded-link matrix as a required CI gate

Dev.to · 1 hr ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

CNBC · 1 hr ago

Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally

MarketWatch · 1 hr ago

Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.

MarketWatch · 1 hr ago